HK Stock Market Move | GUSHENGTANG (02273) rose more than 5%, AI enables traditional Chinese medicine diagnosis and treatment, institutions are optimistic about the company achieving value revaluation.

GUSHENGTANG (02273) rose over 5%, as of press time, up 5.57% to HK$36 with a trading volume of HK$115 million. On the news front, recently, GUSHENGTANG announced the official integration of DeepSeek. The company stated that integrating DeepSeek is an attempt to promote the application of AI technology in medical scenarios, accelerate the development of industry-scale models and intelligent medical solutions. As time progresses, the integration of the two will become closer and will surely create a new era of intelligent healthcare. It is worth mentioning that on February 19, Goldman Sachs FICC and stock department released the "China AI Medical Index" report, with GUSHENGTANG being selected for its advanced layout and innovative practices in the field of AI. China Securities Co., Ltd. pointed out that in the future, the company will: 1) empower diagnosis and operation efficiency through AI technology and OMO strategy; 2) further enhance brand penetration through domestic and international expansion; 3) upgrade the transformation of traditional Chinese medicine prescription with data intelligence. Currently, the company's valuation is at a historically low level, and it is optimistic about the company's performance maintaining a rapid growth trend, with the potential for gradual value reevaluation. It maintains a "buy" rating.